Zhengye Biotechnology H1 EPS $(0.06), Same YoY, Sales $7.509M Down From $8.701M YoY
Benzinga Newsdesk 12 hours ago
NewsEarnings
Zhengye Biotechnology (NASDAQ:ZYBT) reported quarterly losses of $(0.06) per share. This is unchanged from the same period last year. The company reported $7.509 million in sales this quarter. This is a 13.70 percent
Zhengye Biotechnology (NASDAQ:ZYBT) reported quarterly losses of $(0.06) per share. This is unchanged from the same period last year. The company reported $7.509 million in sales this quarter. This is a 13.70 percent decrease over sales of $8.701 million the same period last year.